Orthofix Medical Inc. (OFIX) P/E Ratio History
Historical price-to-earnings valuation from 1999 to 2020
Loading P/E history...
OFIX Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 7, 2026, Orthofix Medical Inc. (OFIX) trades at a price-to-earnings ratio of -5.3x, with a stock price of $12.19 and trailing twelve-month earnings per share of $-1.48.
The current P/E is 102% below its 5-year average of 228.4x. Over the past five years, OFIX's P/E has ranged from a low of 14.9x to a high of 2077.0x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.1x, OFIX trades at a 124% discount to its sector peers. The sector includes 242 companies with P/E ratios ranging from 0.0x to 178.0x.
Relative to the broader market, OFIX trades at a notable discount to the S&P 500 median P/E of 25.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our OFIX DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
OFIX P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $2B | 3.7Lowest | - | +307% | |
| $12B | 22.8 | 0.73Best | +423%Best | |
| $112B | 34.8 | 2.34 | +8% | |
| $16B | 23.3 | - | -20% | |
| $17B | 30.5 | - | -25% | |
| $4B | 28.9 | - | +5% | |
| $99B | 21.5 | - | +31% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
OFIX Historical P/E Data (1999–2020)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2020 Q4 | $42.98 | $0.12 | 358.2x | +280% | |
| FY2020 Q3 | Wed Sep 30 2020 00:00:00 GM | $31.14 | $1.20 | 25.9x | -72% |
| FY2019 Q2 | Sun Jun 30 2019 00:00:00 GM | $52.88 | $0.42 | 127.2x | +35% |
| FY2019 Q1 | Sun Mar 31 2019 00:00:00 GM | $56.41 | $0.49 | 114.0x | +21% |
| FY2018 Q4 | Mon Dec 31 2018 00:00:00 GM | $52.49 | $0.71 | 73.4x | -22% |
| FY2018 Q3 | Sun Sep 30 2018 00:00:00 GM | $57.81 | $0.33 | 172.7x | +83% |
| FY2018 Q2 | Sat Jun 30 2018 00:00:00 GM | $56.82 | $0.59 | 96.3x | +2% |
| FY2018 Q1 | Sat Mar 31 2018 00:00:00 GM | $58.78 | $0.75 | 78.4x | -17% |
| FY2017 Q4 | Sun Dec 31 2017 00:00:00 GM | $54.70 | $0.33 | 165.8x | +76% |
| FY2017 Q3 | Sat Sep 30 2017 00:00:00 GM | $47.25 | $0.07 | 675.0x | +616% |
| FY2017 Q2 | Fri Jun 30 2017 00:00:00 GM | $46.48 | $0.42 | 110.7x | +17% |
| FY2016 Q4 | Sat Dec 31 2016 00:00:00 GM | $36.18 | $0.15 | 241.2x | +156% |
Average P/E for displayed period: 94.3x
See OFIX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs OFIX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare OFIX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonOFIX — Frequently Asked Questions
Quick answers to the most common questions about buying OFIX stock.
Is OFIX stock overvalued or undervalued?
OFIX trades at -5.3x P/E, below its 5-year average of 228.4x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does OFIX's valuation compare to peers?
Orthofix Medical Inc. P/E of -5.3x compares to sector median of 22.1x. The discount suggests lower growth expectations or higher risk.
What is OFIX's PEG ratio?
OFIX PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 1999-2020.